KYMERA THERAPEUTICS, INC. — Key Metrics
3 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-4
Book Value Per Share
$19
Free Cash Flow Per Share
$-3
Cash Per Share
$4
Revenue Per Share
$0
OCF Per Share
$-3
Return on Equity
-25.8%
Return on Assets
-22.9%
Return on Invested Capital
-22.9%
Current Ratio
10.47
Quick Ratio
10.47
Asset Turnover
0.03
Days Sales Outstanding
0.00
Days Payables Outstanding
37.37
R&D / Revenue
807.3%
SBC / Revenue
152.8%
Capex / Revenue
3.7%
Working Capital
$788M
Net Current Asset Value
$708M
Invested Capital
$1.58B
OCF / Net Income
0.75
FCF / Net Income
0.75
Accruals Ratio (Sloan)
-4.5%
Net Debt
$-357M
Net Debt / EBITDA
1.05
Capex Coverage
-160.73
Tangible Common Equity
$1.58B
TCE / Total Assets
90.6%
NOPAT
$-276M
Cash ROIC
-19.4%
WC / Revenue
2009.6%
Capex / D&A
0.17
Reinvestment Rate
2.0%
Asset Growth vs Revenue Growth
94.9%
Revenue 5Y CAGR
2.9%
Book Value 5Y CAGR
41.0%
Stock Price (FY-end)
$78
Market Cap
$6.57B
P/S Ratio
167.66
P/B Ratio
4.16
P/TB Ratio
4.16
P/OCF Ratio
—
P/FCF Ratio
—
Enterprise Value
$6.22B
EV / Sales
158.56
EV / FCF
—
FCF Yield
-3.6%
Shareholder Yield
-0.9%
R&D Yield
4.8%
Capex Yield
0.0%
Shares Variation (YoY)
12.6%
Beta (5Y)
1.68
Cost of Equity
12.9%
52W High
$94
52W Low
$21
Trailing Return 1Y
94.0%
Trailing Return 5Y
-3.4%
F-Score (Piotroski)
3.00
Z-Score (Altman)
23.22
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.